Compare BioNTech SE - ADR (BNTX) vs F5 Inc (FFIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs F5 Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while F5 Inc trades at $414 (market cap $23.44B). The key difference: BioNTech SE - ADR and F5 Inc are close in size by market cap, and F5 Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | FFIV | |
|---|---|---|
Market Cap | $23.31B | $23.44B |
Sector | Health | Technology |
52-Week High | $119.34 | $431.26 |
52-Week Low | $83.89 | $223.99 |
Enterprise Value | $6.60B | $22.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →
